The Mechanism of Sertraline-induced [Ca 2+] i Rise in Human PC3 Prostate Cancer Cells

Basic and Clinical Pharmacology and Toxicology

Volumn 109, Issue 2, 2011, Pages 103-110

  Huang, Jong Khing ^a   Chang, Hong Tai ^a   Chou, Chiang Ting ^b   Shu, Su Shung ^a   Kuo, Chun Chi ^c   Tsai, Jeng Yu ^a   Liao, Wei Chuan ^a   Wang, Jue Long ^c   Lin, Ko Long ^a   Lu, Yi Chau ^a   Chen, I Shu ^a   Liu, Shuih Inn ^a   Ho, Chin Man ^a   Jan, Chung Ren ^a  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c TZU HUI INSTITUTE OF TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; CALCIUM ION; MAGNESIUM ION; PHOSPHOLIPASE C; PROTEIN KINASE C; SERTRALINE;

APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CANCER CELL; CELL KILLING; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR CALCIUM; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

ANTIDEPRESSIVE AGENTS; APOPTOSIS; CALCIUM; CALCIUM SIGNALING; CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; MALE; MANGANESE; PROSTATIC NEOPLASMS; SERTRALINE; TYPE C PHOSPHOLIPASES;

EID: 79960285203     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2011.00690.x     Document Type: Article

References (43)

1. Cipriani A, La Ferla T, Furukawa TA, Signoretti A, Nakagawa A, Churchill R et al. Sertraline versus other antidepressive agents for depression. Cochrane Database Syst Rev 2009;2:CD006117.
2. Brown J, O'Brien PM, Marjoribanks J, Wyatt K. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev 2009;2:CD001396.
3. Becker B, Morel N, Vanbellinghen AM, Lebrun P. Blockade of calcium entry in smooth muscle cells by the antidepressant imipramine. Biochem Pharmacol 2004;68:833-42.
4. Haduch A, Wójcikowski J, Daniel WA. The effect of tricyclic antidepressants, selective serotonin reuptake inhibitors (SSRIs) and newer antidepressant drugs on the activity and level of rat CYP3A. Eur Neuropsychopharmacol 2006;16:178-86.
5. + currents by antidepressant sertraline and paroxetine. J Membr Biol 2008;222:79-90.
6. + currents in rat ventricular myocytes. Yonsei Med J 1999;40:144-51.
7. Ohno Y, Hibino H, Lossin C, Inanobe A, Kurachi Y. Inhibition of astroglial Kir4.1 channels by selective serotonin reuptake inhibitors. Brain Res 2007;1178:44-51.
8. Gil-Ad I, Zolokov A, Lomnitski L, Taler M, Bar M, Luria D et al. Evaluation of the potential anti-cancer activity of the antidepressant sertraline in human colon cancer cell lines and in colorectal cancer-xenografted mice. Int J Oncol 2008;33:277-86.
9. Reddy KK, Lefkove B, Chen LB, Govindarajan B, Carracedo A, Velasco G et al. The antidepressant sertraline downregulates Akt and has activity against melanoma cells. Pigment Cell Melanoma Res 2008;21:451-6.
10. Kalyoncu NI, Ozyavuz R, Karaoglu S. Sertraline inhibits the contractile responses to noradrenaline, KCl and electrical field stimulation of rat isolated vas deferens. J Auton Pharmacol 1999;19:365-9.
11. Medina P, Segarra G, Ballester R, Chuan P, Domenech C, Vila JM et al. Effects of antidepressants in adrenergic neurotransmission of human vas deferens. Urology 2000;55:592-7.
12. Vila JM, Medina P, Segarra G, Lluch P, Pallardó F, Flor B et al. Relaxant effects of antidepressants on human isolated mesenteric arteries. Br J Clin Pharmacol 1999;48:223-9.
13. Weiss J, Dormann SM, Martin-Facklam M, Kerpen CJ, Ketabi-Kiyanvash N, Haefeli WE. Inhibition of P-glycoprotein by newer antidepressants. J Pharmacol Exp Ther 2003;305:197-204.
14. Bootman MD, Berridge MJ, Roderick HL. Calcium signalling: more messengers, more channels, more complexity. Cur Biol 2002;12:R563-5.
15. Clapham DE. Intracellular calcium. Replenishing the stores. Nature 1995;375:634-5.
16. 2+mobilization in platelets. Eur J Pharmacol 1995;288:373-7.
17. 2+fluxes in Madin-Darby canine renal tubular cells. J Recept Signal Transduct Res 2009;29:342-8.
18. 2+movement and proliferation in human prostate cancer cells. Clin Exp Pharmacol Physiol 2004;31:444-9.
19. 2+levels and the growth of human prostate cancer PC3 cells. Clin Exp Pharmacol Physiol 2005;32:735-41.
20. i elevation. Toxicology 2008;250:9-14.
21. 2+mobilization and cytotoxicity in human PC3 prostate cancer cells. J Recept Signal Transduct Res 2006;26:199-212.
22. 2+indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440-50.
23. Merritt JE, Jacob R, Hallam TJ. Use of manganese to discriminate between calcium influx and mobilization from internal stores in stimulated human neutrophils. J Biol Chem 1989;264:1522-7.
24. Young RC, Schumann R, Zhang P. Nifedipine block of capacitative calcium entry in cultured human uterine smooth-muscle cells. J Soc Gynecol Investig 2001;8:210-5.
25. Harper JL, Camerini-Otero CS, Li AH, Kim SA, Jacobson KA, Daly JW. Dihydropyridines as inhibitors of capacitative calcium entry in leukemic HL-60 cells. Biochem Pharmacol 2003;65:329-38.
26. Quinn T, Molloy M, Smyth A, Baird AW. Capacitative calcium entry in guinea pig gallbladder smooth muscle in vitro. Life Sci 2004;74:1659-69.
27. Van Esch GJ. Toxicology of tert-butylhydroquinone (TBHQ). Food Chem Toxicol 1986;24:1063-5.
28. 2+-ATPase. Pro Natl Acad Sci USA 1990;87:2466-70.
29. Thompson AK, Mostafapour SP, Denlinger LC, Bleasdale JE, Fisher SK. The aminosteroid U-73122 inhibits muscarinic receptor sequestration and phosphoinositide hydrolysis in SK-N-SH neuroblastoma cells. A role for Gp in receptor compartmentation. J Biol Chem 1991;266:23856-62.
30. Florenzano F, Viscomi MT, Mercaldo V, Longone P, Bernardi G, Bagni C et al. P2X2R purinergic receptor subunit mRNA and protein are expressed by all hypothalamic hypocretin/orexin neurons. J Com Neurol 2006;498:58-67.
31. Tsien RY. New calcium indicators and buffers with high selectivity against magnesium and protons: design, synthesis, and properties of prototype structures. Biochemistry 1980;19:2396-404.
32. Kaddour-Djebbar I, Choudhary V, Brooks C, Ghazaly T, Lakshmikanthan V, Dong Z et al. Specific mitochondrial calcium overload induces mitochondrial fission in prostate cancer cells. Int J Oncol 2010;36:1437-44.
33. 2+influx and IL-2 production in T lymphocytes. J Immunol 2003;170:4441-9.
34. 2+channel currents of Kupffer cells after hepatic ischemia/reperfusion injury in rats. World J Gastroenterol 2006;12:4694-8.
35. 2+entry into rat sensory neurons. Neurosci Lett 2009;451:124-8.
36. Van Haute C, De Ridder D, Nilius B. TRP channels in human prostate. ScientificWorldJournal 2010;10:1597-611.
37. Giambalvo CT, Price LH. Effects of fenfluramine and antidepressants on protein kinase C activity in rat cortical synaptoneurosomes. Synapse 2003;50:212-22.
38. Tadokoro C, Kiuchi Y, Yamazaki Y, Oguchi K, Kamijima K. Effects of imipramine and sertraline on protein kinase activity in rat frontal cortex. Eur J Pharmacol 1998;342:51-4.
39. 2+channel. J Biol Chem 2010;285:25720-30.
40. 2+entry pathway by PKC-epsilon in vascular SMCs. Am J Physiol Cell Physiol 2008;294:C1499-508.
41. SundarRaj S, Soni C, Karande AA. Glycodelin A triggers T cell apoptosis through a novel calcium-independent galactose-binding lectin activity. Mol Immunol 2009;46:3411-9.
42. 2+-independent phospholipase A2 and 5-lipoxygenase in macrophages. Prostaglandins Other Lipid Mediat 2009;88:51-61.
43. Mauri MC, Laini V, Cerveri G, Scalvini ME, Volonteri LS, Regispani F et al. Clinical outcome and tolerability of sertraline in major depression: a study with plasma levels. Prog Neuropsychopharmacol Biol Psychiatry 2002;26:597-601.